title: Positron emission tomography in non-medullary thyroid cancer.
abstract: While iodine scanning is the mainstay of functional imaging in differentiated thyroid cancer, there is now a significant body of literature regarding positron emission tomography with 2-fluoro-2-deoxy glucose in thyroid cancer. This clinical review will examine the evidence supporting the use of 2-fluoro-2-deoxy glucose-positron emission tomography throughout the diagnosis and management of thyroid cancer, and provide suggestions for its clinical use and potential future roles.
authors.affiliation: Department of Nuclear Medicine and PET, Liverpool Hospital, Liverpool, New South Wales, Australia. i.hoshon@unsw.edu.au
authors.forename: Ivan
authors.initials: I
authors.lastname: Ho Shon
authors.forename: Barbara
authors.initials: B
authors.lastname: Depcynzski
authors.forename: Michael
authors.initials: M
authors.lastname: Lin
authors.forename: Jonathan R
authors.initials: JR
authors.lastname: Clark
authors.forename: Vincent
authors.initials: V
authors.lastname: Wong
authors.forename: Peter
authors.initials: P
authors.lastname: Lin
authors.forename: Peter
authors.initials: P
authors.lastname: Campbell
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D055088:Early Detection of Cancer; D019788:Fluorodeoxyglucose F18; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009367:Neoplasm Staging; D011159:Population Surveillance; D049268:Positron-Emission Tomography; D011379:Prognosis; D012680:Sensitivity and Specificity; D013954:Thyroglobulin / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D016606:Thyroid Nodule / Q000000981:diagnostic imaging; D013972:Thyrotropin / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D019788:Fluorodeoxyglucose F18; D013972:Thyrotropin; D013954:Thyroglobulin